Key Record Dates
ClinicalTrials.gov Identifier: | NCT02372227 |
---|---|
Brief Title: | A Phase 1 Dose Escalation Study of VS-5584 Administered in Combination With VS-6063, in Subjects With Relapsed Malignant Mesothelioma |
First Submitted : | January 30, 2015 |
First Submitted that Met QC Criteria : | February 19, 2015 |
First Posted : | February 26, 2015 (Estimate) |
Last Update Submitted that Met QC Criteria : | January 26, 2017 |
Last Update Posted : | January 30, 2017 (Estimate) |